[1]	For the period ended June 30, 2026 and 2025, diluted weighted-average common shares outstanding is equal to basic weighted-average common shares, as the Company had no instruments outstanding that could potentially dilute earnings per share in the future.

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
CASH FLOWS FOR OPERATING ACTIVITIES:
Net loss	$ (7,588)	$ (14,191)
Adjustments to reconcile net loss to net cash used in operating activities:
Written off on the amount due to other payable	(4,279)
Gain on disposal of investment		(38,433)
Changes in operating assets and liabilities:
Deposits paid, prepayment and other receivables	(5,940)	(520)
Amount due to a related party		15,393
Other payables and accrued liabilities	17,789	(10,690)
Net cash used in operating activities	(18)	(48,441)
CASH FLOWS FROM INVESTING ACTIVITY:
Proceeds from disposal of investment		40,583
Net cash generated from investing activity		40,583
CASH FLOWS FROM FINANCING ACTIVITIES:
Issuance of shares		42,500
Share subscription received in advance		(42,500)
Net cash provided by financing activities
Effect of exchange rate changes on cash and cash equivalents		436
Net change in cash and cash equivalents	(18)	(7,422)
Cash and cash equivalents, beginning of period	465	12,330
CASH AND CASH EQUIVALENTS, END OF PERIOD	447	4,908
SUPPLEMENTAL CASH FLOWS INFORMATION
Income taxes paid
Interest paid

Condensed Consolidated Balance Sheets - USD ($)	Jun. 30, 2026	Dec. 31, 2025
CURRENT ASSETS
Accounts receivable, net
Deposits paid, prepayment and other receivables	8,302	7,104
Cash and cash equivalents	447	465
Total current assets	8,749	7,569
NON-CURRENT ASSETS
Investment in other companies	2,915	2,915
Total non-current assets	2,915	2,915
TOTAL ASSETS	11,664	10,484
CURRENT LIABILITIES
Account payable	285,200	285,200
Other payables and accrued liabilities	115,518	106,750
Total current liabilities	400,718	391,950
TOTAL LIABILITIES	400,718	391,950
STOCKHOLDERS’ DEFICIT
Preferred shares, $0.0001 par value; 200,000,000 shares authorized; None issued and outstanding
Common stock, $0.0001 par value, 600,000,000 shares authorized, 92,562,343 shares issued and outstanding as of June 30, 2026 and December 31, 2025 respectively	9,256	9,256
Additional paid-in capital	702,454	702,454
Accumulated deficit	(1,100,764)	(1,093,176)
TOTAL STOCKHOLDERS’ DEFICIT	(389,054)	(381,466)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT	$ 11,664	$ 10,484